Head-to-head · WeighScore
Bioverse vs Maven Clinic
By GLP-1 ScorecardUpdated
Score comparison
Bioverse has the higher recorded score — 61.4/100 to 58/100.
Bioverse grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Bioverse (GoBioverse) offers compounded semaglutide and tirzepatide plus brand-name Ozempic, Wegovy, and Mounjaro.
Before you choose
Before comparing the headline prices, the Bioverse review and the Maven Clinic review set out what each semaglutide figure in the table below covers, including whether the medication is a brand-name product billed by a pharmacy. Brand-name and compounded prices are different products, so set like against like before treating either one as cheaper.
If neither one fits, Bioverse vs Measured and Bodi Envi vs Maven Clinic compare each of them with another graded program, and the list of alternatives to Bioverse ranks the programs closest to Bioverse on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.
Of the sellers that pay us a commission, the HumeCare+ review covers one graded close to these two, at 58.6/100. That relationship never changes a grade, and the review lists what we could not verify.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Bioverse | Maven Clinic |
|---|---|---|
| WeighScore | 61.4/100 | 58/100 |
| Grade | C | C |
| Site position | #317 | #417 |
| Semaglutide | $129/mo (starting dose, compounded) | Brand Wegovy from $149/mo (pill) or $199/mo (pen), paid to the pharmacy; plus membership of $39 the first month, then $74-$99/mo |
| Tirzepatide | $399/mo (starting dose, compounded) | Brand Zepbound from $299/mo, paid to the pharmacy; plus membership of $39 the first month, then $74-$99/mo |
| Coverage | Coverage not published | Coverage not published |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Not confirmed | Not confirmed |
FDAWarning letter issued to Bioverse, Inc. dba Bioverse in September 2025. See the FDA warning-letter database.
Strengths
- Wide formulary — compounded and brand-name semaglutide + tirzepatide plus metformin
- No membership, cancellation, doctor, or hidden fees
- Uses US-licensed, FDA-regulated pharmacies
What to consider
- No visible LegitScript or PCAB accreditation
- State availability not disclosed beyond 'a provider licensed in your state'
- Broader longevity platform (NAD+, B12, glutathione, hair, skincare, heart health) rather than GLP-1 focused
- FDA issued Bioverse, Inc. dba Bioverse a warning letter in September 2025; the letter is public in FDA's warning-letter database
Strengths
- Dedicated GLP-1 Care program with brand-name (FDA-approved) GLP-1 prescriptions
- On-demand visits with metabolic and hormone-health specialists, plus nutrition and strength support
- Integrated with broader women's, hormone, and family health care
- LegitScript-verified; trusted by 2,300+ employers
- Available as both an employer health benefit and a consumer self-pay option
What to consider
- Pricing is not published on the public site
- Primarily distributed through employers and health plans — direct access can depend on your plan
- US state availability for GLP-1 is not specified publicly
- Brand-name only — no lower-cost compounded option
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.